Macrophages are the most abundant immune cells within the synovial joints, and also the
main innate immune effector cells triggering the initial inflammatory responses in the …

Osteoarthritis (OA) is a prevalent degenerative joint disease characterized by cartilage loss
and accounts for a major source of pain and disability worldwide. However, effective …

Osteoarthritis (OA) is a low‐grade inflammatory and progressive joint disease, and its
progression is closely associated with an imbalance in M1/M2 synovial macrophages …

Osteoarthritis (OA) is a progressive joint disease characterized by inflammation and
cartilage destruction, and its progression is closely related to imbalances in the M1/M2 …

Osteoarthritis (OA) is a chronic osteoarthropathy characterized by the progressive
degeneration of articular cartilage and synovial inflammation. Early OA clinical treatments …

Owing to the rapid aging of society, the numbers of patients with joint disease continue to
increase. Accordingly, a large number of patients require appropriate treatment for …

Osteoarthritis (OA) is a musculoskeletal disease characterized by cartilage degeneration
and stiffness, with chronic pain in the affected joint. It has been proposed that OA …

Osteoarthritis (OA) can be defined as the result of pathological processes of various
etiologies leading to damage to the articular structures. Although the mechanism of …

Pain imposes a significant urden on patients, affecting them physically, psychologically, and
economically. Despite numerous studies on the pathogenesis of pain, its clinical …

We undertook this study to investigate the effects and mechanisms of dexamethasone
liposome (Dex-Lips) on alleviating destabilization of the medial meniscus (DMM)-induced …